{"disease":{"id":"idh1-gene-mutation","name":"idh1 gene mutation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04369287","title":"Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia","phase":"","overall_status":"UNKNOWN","enrollment_count":654,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT03749187","title":"BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":78,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT07007949","title":"a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT03303950","title":"Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"University of Utah","has_results":true},{"nct_id":"NCT04955938","title":"A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Chicago","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}